|
Takemoto
M, Yamaga M, Furuichi Y,
Yokote K.
Astaxanthin
Improves Nonalcoholic Fatty Liver Disease in Werner Syndrome with
Diabetes Mellitus. J Am Geriatr Soc. 63,
1271-3. 2015.
Sanada
S, Futami K, Terada A, Yonemoto K,
Ogasawara S, Akiba J, Yasumoto
M, Sumi A, Ushijima K, Kamura T, Furuichi Y,
Yano H.
RECQL1 DNA repair
helicase: a potential therapeutic target and a proliferative marker
against ovarian cancer. PLoS One. 8, e72820. 2013.
De S, Kumari
J, Mudgal R, Modi P, Gupta S, Futami K,
Goto H, Lindor
NM, Furuichi Y, Mohanty D, Sengupta S.
RECQL4 is essential for the
transport of p53 to mitochondria in normal human cells in the absence
of exogenous stress. J Cell Sci. 125, 2509-2522. 2012.
Arai A, Chano T, Futami
K, Furuichi Y, Ikebuchi K, Inui
T, Tameno H, Ochi Y, Shimada T, Hisa Y, Okabe H.
RECQL1 and WRN Proteins Are
Potential Therapeutic Targets in Head and Neck Squamous Cell
Carcinoma. Cancer Res. 71, 4598-4607. 2011.
Kataoka
K, Kono Y, Sugtimoto
M, Furuichi Y, Shichiri M, Tanaka Y.
Hepatocyte-protective
and anti-oxidant effects of rifampicin on human chronic hepatitis C
and murine acute hepatocyte disorder. Exp Ther Med. 1,
1041. 2010.
Futami
K, Kumagai E, Makino H, Sato A, Takagi M, Shimamoto A, Furuichi Y.
Anticancer
activity of RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci. 99, 1227-1236, 2008.
Futami K,
Ishikawa Y, Goto M, Furuichi
Y, Sugimoto M.
Role of WRN helicase in
carcinogenesis and in resistance by cancer cells to genotoxins. Cancer
Sci. 99, 843-848,
2008.
Futami K, Kumagai E, Makino H, Goto H, Takagi M, Shimamoto
A, Furuichi Y.
Induction
of mitotic cell death in cancer cells by small interference RNA
suppressing the expression of RecQL1 helicase. Cancer Sci. 99, 71-80, 2008.
Futami K, Takagi M, Shimamoto
A, Sugimoto M, Furuichi Y.
Increased chemotherapeutic
activity of camptothecin in cancer cells by
siRNA-induced silencing of WRN helicase. Biol
Pharm Bull. 30,
1958-1961, 2007.
|
